Equity Profile

HOLX

Hologic, Inc.

Health CareHealth Care Equipment

May1Thu

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Hologic, Inc. is a health care company focused on women's health, offering innovative medical devices and diagnostics....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and is closely watched by investors.

$1.09

Revenue Growth

Revenue growth is essential for assessing the company's ability to expand its market share and sustain operations.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

HOLX Q2-2026 Earnings Preview

Context

Company Snapshot

Hologic, Inc. is a health care company focused on women's health, offering innovative medical devices and diagnostics. As part of the health care equipment sector, Hologic plays a crucial role in advancing technologies for early disease detection and treatment.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

-1.56%

Avg Stock Reaction

+0.13%

Last Quarter Recap

In Q1-2026, Hologic reported an EPS of $1.04, slightly missing the estimate of $1.09. The stock reacted with a minor decline of 0.16% the following day.

Management Promises & Guidance

Focus on expanding product offerings in women's health.
Commitment to improving operational efficiencies.
Plans to enhance customer engagement and support.

Expectations

Wall Street Expectations

Overall, expectations for Hologic's upcoming earnings are mixed, with some analysts anticipating a rebound in EPS after a slight miss last quarter.

Bull Case

If Hologic can exceed EPS expectations and demonstrate strong revenue growth, it could signal a recovery and boost investor confidence.

Bear Case

Conversely, if the company fails to meet EPS estimates again, it may raise concerns about its growth trajectory and operational challenges.

Key Metrics to Watch

Earnings Per Share (EPS)

$1.09

EPS is a key indicator of the company's profitability and is closely watched by investors.

Revenue Growth

N/A

Revenue growth is essential for assessing the company's ability to expand its market share and sustain operations.

Gross Margin

N/A

Gross margin reflects the efficiency of production and pricing strategy, impacting overall profitability.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Hologic's EPS exceed $1.09 this quarter?

A beat on EPS would signal a recovery in profitability and could positively influence investor sentiment.

What are the latest trends in revenue growth for Hologic's product lines?

Understanding revenue trends will help assess the company's market position and future growth potential.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Hologic's potential for a strong rebound in EPS, given recent product launches and market demand.

Supporting Evidence

Options pricing suggests a significant move, indicating heightened expectations.

Hologic's historical EPS beat rate of 75% suggests a strong likelihood of exceeding estimates.

Recent product innovations could drive unexpected revenue growth.

Key Risk

If the EPS comes in below $1.04, it could challenge the current bullish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter, the focus is on whether Hologic can rebound from its last earnings miss and demonstrate solid growth.

Bull Confirmed If

An EPS of $1.10 or higher would confirm the bullish outlook.

Bear Confirmed If

An EPS below $1.04 would reinforce concerns about operational challenges.

Pre-Earnings Positioning

Options Market

Implied Move

±40.8%

Historical Avg

±1.1%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±40.8% while HOLX has averaged ±1.1% over the last 8 prints — setup is pricing rich.

Detail

30d HV

2.7%

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Hologic beats expectations, history suggests the stock could see a moderate increase, confirming a positive trend.

In-Line / Cautious

If results are in line with expectations, the stock may remain stable, but cautious commentary could lead to volatility.

Miss

Should Hologic miss expectations again, the stock could decline, as history indicates a tendency for negative reactions.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on new product launches and their market reception.
2Any commentary on cost management and operational efficiencies.
3Insights into customer engagement strategies and their effectiveness.
4Trends in demand for women's health products.
5Management's outlook on future revenue growth.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Moelis & Company

Company Snapshot

Hologic, Inc. is a health care company focused on women's health, offering innovative medical devices and diagnostics....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and is closely watched by investors.

$1.09

Revenue Growth

Revenue growth is essential for assessing the company's ability to expand its market share and sustain operations.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

HOLX Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

-1.56%

Avg Stock Reaction

+0.13%

Last Quarter Recap

In Q1-2026, Hologic reported an EPS of $1.04, slightly missing the estimate of $1.09. The stock reacted with a minor decline of 0.16% the following day.

Management Promises & Guidance

Focus on expanding product offerings in women's health.
Commitment to improving operational efficiencies.
Plans to enhance customer engagement and support.

Expectations

Wall Street Expectations

Overall, expectations for Hologic's upcoming earnings are mixed, with some analysts anticipating a rebound in EPS after a slight miss last quarter.

Bull Case

If Hologic can exceed EPS expectations and demonstrate strong revenue growth, it could signal a recovery and boost investor confidence.

Bear Case

Conversely, if the company fails to meet EPS estimates again, it may raise concerns about its growth trajectory and operational challenges.

Key Metrics to Watch

Earnings Per Share (EPS)

$1.09

EPS is a key indicator of the company's profitability and is closely watched by investors.

Revenue Growth

N/A

Revenue growth is essential for assessing the company's ability to expand its market share and sustain operations.

Gross Margin

N/A

Gross margin reflects the efficiency of production and pricing strategy, impacting overall profitability.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Hologic's EPS exceed $1.09 this quarter?

A beat on EPS would signal a recovery in profitability and could positively influence investor sentiment.

What are the latest trends in revenue growth for Hologic's product lines?

Understanding revenue trends will help assess the company's market position and future growth potential.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Hologic's potential for a strong rebound in EPS, given recent product launches and market demand.

Supporting Evidence

Options pricing suggests a significant move, indicating heightened expectations.

Hologic's historical EPS beat rate of 75% suggests a strong likelihood of exceeding estimates.

Recent product innovations could drive unexpected revenue growth.

Key Risk

If the EPS comes in below $1.04, it could challenge the current bullish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter, the focus is on whether Hologic can rebound from its last earnings miss and demonstrate solid growth.

Bull Confirmed If

An EPS of $1.10 or higher would confirm the bullish outlook.

Bear Confirmed If

An EPS below $1.04 would reinforce concerns about operational challenges.

Pre-Earnings Positioning

Options Market

Implied Move

±40.8%

Historical Avg

±1.1%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±40.8% while HOLX has averaged ±1.1% over the last 8 prints — setup is pricing rich.

Detail

30d HV

2.7%

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Hologic beats expectations, history suggests the stock could see a moderate increase, confirming a positive trend.

In-Line / Cautious

If results are in line with expectations, the stock may remain stable, but cautious commentary could lead to volatility.

Miss

Should Hologic miss expectations again, the stock could decline, as history indicates a tendency for negative reactions.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on new product launches and their market reception.
2Any commentary on cost management and operational efficiencies.
3Insights into customer engagement strategies and their effectiveness.
4Trends in demand for women's health products.
5Management's outlook on future revenue growth.